Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content

• Fausto Machicao ,

  Contributed equally to this work with: Fausto Machicao, Andreas Peter

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany

  ⨯
• Andreas Peter ,

  Contributed equally to this work with: Fausto Machicao, Andreas Peter

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Jürgen Machann,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Ingmar Königsrainer,

  Affiliation Department of General, Visceral, and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Anja Böhm,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Stefan Zoltan Lutz,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Martin Heni,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Andreas Fritsche,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany, Department of Internal Medicine, Division of Nutritional and Preventive Medicine, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Fritz Schick,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Alfred Königsrainer,

  Affiliation Department of General, Visceral, and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Norbert Stefan,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Hans-Ulrich Häring,

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Harald Staiger

  * E-mail: harald.staiger@med.uni-tuebingen.de

  Affiliations Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany, German Center for Diabetes Research (DZD), Tübingen, Germany, Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany

  ⨯